Eyam Welcomes Wolfgang Koester to Board of Directors

March 18, 2024 7:30 AM

VANCOUVER, BC / ACCESSWIRE / March 18, 2024 / Eyam Vaccines and Immunotherapeutics is pleased to announce the appointment of Wolfgang Koester to the Board of Directors, one of the "100 Most Influential People in Finance". This strategic addition underscores Eyam's commitment to increase collaboration with global companies on their proven AI driven bioinformatics platform and innovative self-amplifying platforms to design and deliver vaccines...

Read more

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity

March 15, 2024 9:00 AM

Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, March 21st at 12:00 PM ETIRVINE, CA / ACCESSWIRE / March 15, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that it will present at the Virtual Investor Lunch Break: The enVVeno Opportunity event on Thursday, March 21, 2024 at...

Read more

Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production

March 15, 2024 9:00 AM

New Location Positions CIL for Product Development and Future GrowthTEWKSBURY, MA / ACCESSWIRE / March 15, 2024 / Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), has announced it will be relocating and expanding its corporate headquarters to newly purchased space in Tewksbury, MA, to advance the operations and growth of the company. The purchase was made in June...

Read more

Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results

March 15, 2024 8:00 AM

Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical PlansSAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today reported financial results for the fourth quarter and full year of 2023.Dr....

Read more

Ondine Biomedical Inc. Announces Steriwave Deploying in Eight New Sites

March 15, 2024 3:00 AM

Steriwave deploying in eight new sitesVANCOUVER, BC / ACCESSWIRE / March 15, 2024 / Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments to prevent and treat healthcare-associated infections (HAIs), has made significant commercial progress to date in 2024, ahead of management's expectations. Ondine's Steriwave® technology is deploying in eight new healthcare facilities,...

Read more

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer

March 14, 2024 9:20 AM

KELOWNA, BC / ACCESSWIRE / March 14, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. As a member of the executive leadership team, Mr. Cabatuan will lead the Company's financial operations."Nelson's deep financial leadership experience will be...

Read more

Form Bio Helps Life Sciences Professionals Transform Omics Data Into Breakthrough Insights Through Google Cloud

March 14, 2024 8:00 AM

Google Cloud's Powerful AI Models for Healthcare and Life Sciences Research Now Available as Point-and-Click Workflows via Form Bio's Bioinformatics Platform, Available on Google Cloud MarketplaceDALLAS, TX / ACCESSWIRE / March 14, 2024 / Form Bio, the breakthrough computational life sciences solutions provider, today announced the availability of Google Cloud's innovative AI-based models for healthcare and life sciences research as...

Read more

Q3 Interim Report November-January 2023/2024

March 14, 2024 3:20 AM

UPPSALA, SE / ACCESSWIRE / March 14, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Several new commercial agreements signed and evidence that DiviTum® TKa significantly improves clinical routines in the USA.SEK tQ3 23/24Q3 22/23May-Jan 23/24May-Jan 22/23Full year 22/23Net sales1,0759265,3912,4323,383Operating profit (loss)-27,848-29,277-85,355-73,250-110,457Earnings per share, after dilution-0.44-0.64-1.66-2.33-3.17Number of...

Read more

Canyon Labs Announces New Leadership Hires

March 13, 2024 9:00 AM

Canyon Labs Hires Sales and Technical Business Development LeadershipSALT LAKE CITY, UT / ACCESSWIRE / March 13, 2024 / Canyon Labs, a leader in testing and regulatory consulting for medical devices and pharmaceuticals, announces today the hire of new company leadership. These new hires will bring industry expertise to continue to elevate the offerings and business solutions to current and future customers.Kyle Kempf, Vice President of Sales and...

Read more

Chief Financial Officer (CFO) Ole Larsen Buys Shares

March 13, 2024 6:35 AM

KØBENHAVN, DK / ACCESSWIRE / March 13, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - 13 March 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today announces that Ole Larsen (CFO) has bought shares.Member of the Executive Management Ole Larsen has bought 529 shares in the Company at an average share price of SEK 54.364.After the buy, Ole holds 3,000 shares in the Company.For further information, please contact: Morten Albrechtsen,...

Read more

Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update

March 13, 2024 6:30 AM

LUXEMBOURG / ACCESSWIRE / March 13, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023. Moolec Logo Moolec Science Logo The main highlights of Moolec's business update are as follows:SOOY1 | Piggy Sooy™ Platform: Third generation...

Read more

AbTherx Partners with Single Cell Technology for First Antibody Discovery Campaigns

March 13, 2024 6:00 AM

Partnership provides AbTherx and licensees of AbTherx's Atlas™ Mice access to Single Cell Technology's proprietary single B cell screening engineMOUNTAIN VIEW AND SAN JOSE, CA / ACCESSWIRE / March 13, 2024 / AbTherx, Inc., a biotechnology company with innovative technologies to enable and accelerate antibody discovery, and Single Cell Technology, Inc. ("Single Cell"), a biotechnology company with nine years of experience delivering antibodies to...

Read more

Interventional DiviTum(R) TKa Trial Launches at Washington University

March 13, 2024 3:50 AM

UPPSALA, SWEDEN / ACCESSWIRE / March 13, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, today announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis. The study is aimed at evaluating whether patients with HR+ HER2- metastatic or unresectable breast cancer benefit from DiviTum® TKa"We are thrilled to once again...

Read more

Bioriginal and POS Biosciences Launch Sustainable Omega-3 Line

March 12, 2024 4:10 PM

SASKATOON, SK / ACCESSWIRE / March 12, 2024 / Bioriginal Food & Science Corp. ("Bioriginal"), a wholly owned subsidiary of Cooke Inc. ("Cooke"), has developed a sustainable line of omega-3 fish, algal, and plant based oils with technology from POS Biosciences.Leveraging Cooke's marine resources as a global aquaculture fish farmer, Bioriginal has access to a secure source of sustainable fish oil. Combining these new fish oil products with an...

Read more

Elixirgen Scientific Achieves ISO 9001 QMS Certification

March 12, 2024 9:00 AM

Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.BALTIMORE, MD / ACCESSWIRE / March 12, 2024 / Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing cell therapy through iPSC technology, announced today that it has been accredited...

Read more

Vibrant Wellness Introduces Regenere: A Revolutionary Personalized Skincare Regimen

March 12, 2024 8:15 AM

Harnessing Genetic Insights for Better Skincare SolutionsSANTA CLARA, CA / ACCESSWIRE / March 12, 2024 / Vibrant Wellness, a pioneer in personalized wellness solutions, announced the launch of Regenere - an innovative skincare regimen that redefines personalized skincare. By leveraging genetic insights and detailed skin assessments, Regenere helps address individual skincare needs.Personalized Skincare Receive your personalized skincare solution...

Read more

Canopus Biopharma Inc. (CBIA) dba Blue Heaven Coffee Inc. (BHC) Leads Retail Revolution with Introduction of Innovative Customer Loyalty Program

March 12, 2024 8:00 AM

LAS VEGAS, NV / ACCESSWIRE / March 12, 2024 / Canopus Biopharma Inc. (OTC PINK:CBIA) dba Blue Heaven Coffee Inc. (BHC) is at the forefront of retail innovation with the introduction of its groundbreaking customer loyalty program. Leveraging the success of its AI-powered digital vending machines, BHC has unveiled a pioneering loyalty initiative tailored exclusively for users of its unattended retail network across North America.This innovative...

Read more

Biovica Signs Master Service Agreement

March 12, 2024 3:20 AM

UPPSALA, SE / ACCESSWIRE / March 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a master service agreement with a biopharmaceutical company enabling Biovica to provide its TKa testing assay and testing services. The agreement holds room for several work orders, the first of which is 1.2 MSEK.The service agreement allows Biovica to perform TKa testing services...

Read more

Prolocor Announces Appointment of Raymond Russo as Chief Commercial Officer

March 11, 2024 8:00 AM

PHILADELPHIA, PA / ACCESSWIRE / March 11, 2024 / Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa (pFCG test), today announced the appointment of Raymond Russo as Chief Commercial Officer. Mr. Russo is a seasoned biotech executive with significant operational, commercial, and strategic leadership experience across cardiovascular and...

Read more

GenEmbryomics Prepares for US National Exchange Listing with Appointment of Independent US-Based Director

March 7, 2024 5:15 PM

MELBOURNE, AUSTRALIA / ACCESSWIRE / March 7, 2024 / GenEmbryomics, a medical genetics company with world-leading intellectual property, today announced the appointment of an additional independent director to its Board. This strategic move is part of the company's preparation for listing on a major US national exchange, underlining its commitment to global expansion and enhancing corporate governance standards."We are thrilled to welcome Tess...

Read more